Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 14 matching records.
14 results — page 1 of 1
- Level DLaboratory StudyEurope PMC
The Histone Deacetylase Inhibitor (MS-275) Promotes Differentiation of Human Dental Pulp Stem Cells into Odontoblast-Like Cells Independent of the MAPK Signaling System
Laboratory Study, published in Int J Mol Sci (2020) — summary generated from the PubMed abstract.
- 2020
Int J Mol Sci20 citations - Level DNarrative ReviewEurope PMC
Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering
Narrative Review on Cardiovascular Disease, published in Int J Oral Sci (2019) — summary generated from the PubMed abstract.
- 2019
Int J Oral Sci55 citations - Level DLaboratory StudyPubMed
Histone Deacetylase Inhibitor (Trapoxin A) Enhances Stemness Properties in Adipose Tissue Derived Mesenchymal Stem Cells.
Laboratory Study, published in Drug Res (Stuttg) (2018) — summary generated from the PubMed abstract.
- 2018
Drug Res (Stuttg) - Level DLaboratory StudyPubMed
A New 2-Step Acceleration Protocol Using a Histone Deacetylase Inhibitor to Generate Insulin-Producing Cells From Adipose-Derived Mesenchymal Stem Cells.
Laboratory Study, published in Pancreas (2018) — summary generated from the PubMed abstract.
- 2018
Pancreas19 citations - Level DLaboratory StudyPubMed
Data for the effect of histone deacetylase inhibitors on voltage- and ligand-gated ion channel gene expression in neurogenic induced-human adipose tissue-derived mesenchymal stem cells.
Laboratory Study, published in Data Brief (2018) — summary generated from the PubMed abstract.
- 2018
Data Brief - Level DAnimal StudyPubMed
Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma.
Animal Study, published in Cancer Lett (2018) — summary generated from the PubMed abstract.
- 2018
Cancer Lett - Level CProspective StudyPubMed
Histone Deacetylase Inhibitors Enhance Cytotoxicity Towards Breast Tumors While Preserving the Wound-Healing Function of Adipose-Derived Stem Cells.
Prospective Study on Chronic Wound, Chronic Inflammation, published in Ann Plast Surg (2017) — summary generated from the PubMed abstract.
- 2017
Ann Plast Surg6 citations - Level DLaboratory StudyPubMed
Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor.
Laboratory Study on Cardiovascular Disease, published in Biomed Eng Online (2017) — summary generated from the PubMed abstract.
- 2017
Biomed Eng Online11 citations - Level DAnimal StudyPubMed
Differentiation of rat adipose tissue-derived stem cells into neuron-like cells by valproic acid, a histone deacetylase inhibitor.
Animal Study, published in Exp Anim (2015) — summary generated from the PubMed abstract.
- 2015
Exp Anim14 citations - Level DAnimal StudyPubMed
Histone deacetylase inhibitor sodium butyrate promotes the osteogenic differentiation of rat adipose-derived stem cells.
Animal Study, published in Dev Growth Differ (2014) — summary generated from the PubMed abstract.
- 2014
Dev Growth Differ20 citations - Level DAnimal StudyPubMed
Valproic acid, a histone deacetylase inhibitor, decreases proliferation of and induces specific neurogenic differentiation of canine adipose tissue-derived stem cells.
Animal Study on Hip, published in J Vet Med Sci (2013) — summary generated from the PubMed abstract.
- 2013
J Vet Med Sci13 citations - Level DAnimal StudyPubMed
Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner.
Animal Study, published in Stem Cells Dev (2012) — summary generated from the PubMed abstract.
- 2012
Stem Cells Dev42 citations - Level CProspective StudyPubMed
Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells.
Prospective Study, published in Cell Prolif (2009) — summary generated from the PubMed abstract.
- 2009
Cell Prolif126 citations - Level DAnimal StudyPubMed
Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Animal Study on Hip, published in J Cell Biochem (2005) — summary generated from the PubMed abstract.
- 2005
J Cell Biochem
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406